In contrast, IGFBP5 tumor tissue levels have been found to be significantly associated with poor disease outcome and the addition of IGFBP4 (measured as IGFBP5/IGFBP4 ratio expression levels) further increased prognostic power [63]. This evidence concerns the gene IGFBP5 and neoplasm.